Related Experiment Video
Updated: Sep 10, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Tanshinone IIA Inhibits NADPH Oxidase 4 Expression by Regulating Sestrin2-Mediated AMPK/mTOR Signaling Pathway to
Congying Guo1,2, Sheng Ai1,2, Mingyu Wu1,2
1State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu 210009, P. R. China.
Abstract:
Oxidative stress serves as a driving force for myofibroblast activation in pulmonary fibrosis (PF). As a main enzymatic source of reactive oxygen species (ROS), NADPH oxidase 4 (Nox4) plays a critical role in modulating myofibroblast activation, and has thus emerged as a potential therapeutic target for PF. Tanshinone IIA (Tan-IIA), the most abundant fat-soluble component found in the root and rhizome of Salvia miltiorrhiza Bge., has been demonstrated to suppress ROS-mediated myofibroblast activation by inhibiting Nox4, and thereby ameliorating PF. However, the mechanism through which Tan-IIA regulates Nox4 to prevent myofibroblast activation remains unclear. This study aimed to investigate the protective effects of Tan-IIA against myofibroblast activation in PF, and to elucidate the upstream molecular mechanisms involved in Nox4 regulation. Tan-IIA inhibited myofibroblast activation by reducing extracellular matrix deposition in a mouse model of bleomycin-induced PF. Furthermore, Tan-IIA enhanced the expression of Sestrin2 (Sesn2), while concurrently suppressing Nox4 expression. This effect was verified using an in vitro model of transforming growth factor beta 1 (TGF-β1)-stimulated myofibroblast activation. We further demonstrated that Sesn2 was required for Tan-IIA to act against TGF-β1-induced myofibroblast activation by inhibiting Nox4-mediated oxidative stress. Additionally, both in vitro and in vivo studies revealed that Tan-IIA activates AMP-activated protein kinase (AMPK) and inhibits mammalian target of rapamycin (mTOR) via the upregulation of Sesn2. The findings indicate that Tan-IIA suppresses Nox4 by regulating the Sesn2/AMPK/mTOR signaling pathway, which highlights the crucial effect Sesn2 has in modulating Nox4 expression to prevent myofibroblast activation during PF.
Insights
Tanshinone IIA (Tan-IIA) combats pulmonary fibrosis by inhibiting NADPH oxidase 4 (Nox4) and reducing oxidative stress. It achieves this by upregulating Sestrin2 (Sesn2), which activates AMPK and inhibits mTOR, thereby preventing myofibroblast activation.
Area of Science:
- Cell Biology
- Molecular Medicine
- Pharmacology
Background:
- Pulmonary fibrosis (PF) is driven by oxidative stress and myofibroblast activation.
- NADPH oxidase 4 (Nox4) is a key source of reactive oxygen species (ROS) in PF and a therapeutic target.
- Tanshinone IIA (Tan-IIA) from Salvia miltiorrhiza shows potential in ameliorating PF by inhibiting Nox4.
Purpose of the Study:
- To investigate Tan-IIA's protective effects against myofibroblast activation in PF.
- To elucidate the upstream molecular mechanisms by which Tan-IIA regulates Nox4.
- To determine the role of Sestrin2 (Sesn2) in Tan-IIA's mechanism of action.
Main Methods:
- Utilized a mouse model of bleomycin-induced PF.
- Employed in vitro models of transforming growth factor beta 1 (TGF-β1)-stimulated myofibroblast activation.
- Analyzed the expression of Nox4, Sestrin2 (Sesn2), AMP-activated protein kinase (AMPK), and mammalian target of rapamycin (mTOR).
Main Results:
- Tan-IIA inhibited myofibroblast activation and reduced extracellular matrix deposition in vivo.
- Tan-IIA upregulated Sesn2 and suppressed Nox4 expression in both in vitro and in vivo models.
- Sesn2 mediated Tan-IIA's antifibrotic effects by inhibiting Nox4-induced oxidative stress.
- Tan-IIA activated AMPK and inhibited mTOR through Sesn2 upregulation.
Conclusions:
- Tan-IIA suppresses Nox4-mediated oxidative stress and myofibroblast activation in PF.
- The Sesn2/AMPK/mTOR signaling pathway is crucial for Tan-IIA's therapeutic effects.
- Tan-IIA represents a promising therapeutic agent for pulmonary fibrosis by targeting the Sesn2/Nox4 axis.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Related Concept Videos
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades